ChromaDex Corporation (NASDAQ:CDXC) Q1 2023 Results Conference Call May 10, 2023 4:30 PM ET Company Participants Kendall Knysch - Director, Media Relations Rob Fried - Chief Executive Officer Brianna Gerber - Chief Financial Officer Andrew Shao - Senior Vice President-Scientific and Regulatory Affairs Conference Call Participants Jeff Van Sinderen - B. Riley Ram Selvaraju - H.C. Wainwright Mitch Pinheiro - Sturdivant Sean McGowan - ROTH MKM JP Mark - Farmhouse Equity Research Jeff Cohen - Ladenburg Thalmann ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------------------------------------------------------------------------------------|-------|---------------------|-------|---------------------------|------------------------------------------------|-------|---------------------------|-------| | (In thousands except per share data and remaining contractual term) | | Number of Options | | Weighted \nExercise Price | Average \nRemaining Contractual Term (Years) | | Aggregate Intrinsic Value | | | Outs ...

to safely elevate NAD+ levels and the only patented form of nicotinamide riboside (Niagen®) available in the world. Our History (2000-Present) Partnered with Partnered with Launched healthcare practitioner business Announced supply agreement with TRU NIAGEN Singapore New Zealand Commercialized Niagen® (trademarked NR) 2003 2016 2000 2002 2017 2018 2019 2020 2021 2022 Launched Tru Niagen® Beauty with Partnered with Tru Niagen® is the most efficient way to safely elevate NAD+ (1) Related to Nicotinamide Ribos ...

ChromaDex Corporation (NASDAQ:CDXC) Q4 2022 Earnings Conference Call March 8, 2023 4:30 PM ET Company Participants Tom Shumaker – LifeSci Advisors, Agency IR Counsel Rob Fried – Chief Executive Officer Brianna Gerber – Chief Financial Officer Andrew Shao – Senior Vice President-Scientific and Regulatory Affairs Conference Call Participants Mitch Pinheiro – Sturdivant Jeff Van Sinderen – B. Riley Ram Selvaraju – H.C. Wainwright Destiny Hance – Ladenburg Thalmann Sean McGowan – Roth MKM Bill Dezellem – Tieton ...

Ingredients Segment Analytical Reference Standards and Services Segment According to data from Global Wellness Institute, the global wellness industry market was approximately $4.4 trillion in 2020 amidst the disruptions of COVID-19, which is down from $4.9 trillion in 2019. In 2020, the personal care, beauty and anti-aging market was approximately $960 billion, healthy eating, nutrition and weight loss was approximately $950 billion and traditional and complementary medicine market was approximately $410 b ...

ChromaDex Corporation (NASDAQ:CDXC) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Tom Shumaker - Investor Relations Robert Fried - Chief Executive Officer Brianna Gerber - Interim Chief Financial Officer Conference Call Participants Jeff Cohen - Ladenburg Thalmann Sean McGowan - ROTH Capital Jeff Van Sinderen - B. Riley Mitchell Pinheiro - Sturdivant & Company Brian Nagel - Oppenheimer Operator Ladies and gentlemen, thank you for standing by, and welcome to ChromaDex Corp ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) | --- | --- | --- | |----------------------------------------------------------------------------------|----------------------------|---------------------------------------------- ...

ChromaDex Corporation (NASDAQ:CDXC) Q2 2022 Results Conference Call August 10, 2022 4:30 AM ET Company Participants Heather Van Blarcom - Senior Vice President of Legal and Corporate Secretary Robert Fried - Chief Executive Officer Kevin Farr - Chief Financial Officer Brianna Gerber - Vice President of Finance and Investor Relations Conference Call Participants Brian Nagel - Oppenheimer Mitchell Pinheiro - Sturdivant Raghuram Selvaraju - H.C. Wainwright Sean McGowan - ROTH Capital Jeffrey Cohen - Ladenburg ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) | --- | --- | --- | |----------------------------------------------------------------------------------|----------------------------|--------------------------------------------------- ...

| --- | --- | |--------------------------|-------| | | | | ChromaDex | | | | | | | | | | | | Earnings Conference Call | | | | | | First Quarter 2022 | | Rob Fried Chief Executive Officer Frank Jaksch Co-Founder / Executive Chairman Kevin Farr Chief Financial Officer Nasdaq: CDXC | May 2022 SAFE HARBOR STATEMENT 2 This presentation and other written or oral statements made from time to time by representatives of ChromaDex contain "forward-looking statements" within the meaning of Section 27A of the Securitie ...